Stockscreener 앱 받기
55.81
1.15%
-0.65
시간 외 거래:
55.69
-0.12
-0.22%
전일 마감가:
$56.46
열려 있는:
$56.74
하루 거래량:
10.28M
Relative Volume:
1.07
시가총액:
$72.42B
수익:
$363.25B
순이익/손실:
$7.19B
주가수익비율:
8.4178
EPS:
6.63
순현금흐름:
$5.27B
1주 성능:
-1.20%
1개월 성능:
-9.31%
6개월 성능:
-0.89%
1년 성능:
-18.80%
1일 변동 폭
$55.62
$57.23
1주일 범위
$55.62
$57.72
52주 변동 폭
$52.77
$83.25
CVS헬스 Stock (CVS) Company Profile
명칭
Cvs Health Corp
전화
(401) 765-1500
주소
ONE CVS DR., WOONSOCKET
CVS헬스 Stock (CVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-10-04 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-05-30 | 개시 | Robert W. Baird | Neutral |
| 2024-05-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-05-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-01 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2023-12-22 | 개시 | HSBC Securities | Buy |
| 2023-09-19 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-09-12 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2023-05-26 | 개시 | Piper Sandler | Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 재개 | Morgan Stanley | Overweight |
| 2022-06-17 | 개시 | Loop Capital | Buy |
| 2022-05-27 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-02-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | 개시 | Goldman | Buy |
| 2021-12-01 | 개시 | Seaport Research Partners | Buy |
| 2021-05-19 | 개시 | Wells Fargo | Equal Weight |
| 2021-03-17 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-01-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-09-17 | 개시 | Piper Sandler | Overweight |
| 2020-07-01 | 개시 | SVB Leerink | Mkt Perform |
| 2020-05-14 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | 재개 | RBC Capital Mkts | Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Buy |
| 2019-06-05 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2019-04-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | 개시 | Guggenheim | Buy |
| 2019-04-15 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2019-04-10 | 재확인 | BofA/Merrill | Buy |
| 2019-03-13 | 개시 | Bernstein | Outperform |
| 2019-02-20 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | 개시 | UBS | Buy |
| 2018-12-18 | 개시 | Barclays | Overweight |
| 2018-11-29 | 재개 | Goldman | Neutral |
| 2018-11-28 | 개시 | Evercore ISI | Outperform |
| 2018-10-26 | 재개 | Wolfe Research | Peer Perform |
| 2018-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-02-27 | 재개 | BofA/Merrill | Buy |
| 2018-02-13 | 재확인 | Citigroup | Neutral |
모두보기
CVS헬스 주식(CVS)의 최신 뉴스
US Bancorp DE Cuts Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS faces credit rating review as debt leverage climbs - The Business Journals
CVS Health Stock: Analyst Estimates & Ratings - Barchart
Willow Grove man charged with insider trading after making $617K on CVS Health deal - Glenside Local
Curious about CVS Health (CVS) Q3 Performance? Explore Wall Street Estimates for Key Metrics - Yahoo Finance
Willow Grove man faces insider trading charges after CVS-Oak Street deal - The Philadelphia Inquirer
CVS Unit Exec's Ex-Partner Charged With Insider Trading - Law360
Scientist Charged With Trading on Domestic Partner’s Deal Secret - Bloomberg
SEC Sues Scientist for Insider Trading in CVS-Oak Street Merger - Bloomberg Law
Pennsylvania man charged with insider trading related to CVS takeover - MSN
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
Pennsylvania man charged with insider trading related to CVS takeover By Reuters - Investing.com
CVS Credit Rating at Risk After Growth Gamble Fails to Pay Off - Bloomberg
CVS Health Corporation (CVS): Among The 10 Oversold Blue Chip Stocks to Buy Now - Insider Monkey
CVS Health Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
10 Oversold Blue Chip Stocks to Buy Now - Insider Monkey
Earnings Preview: CVS Health (CVS) Q3 Earnings Expected to Decline - Yahoo Finance
CVS Health Insider Lowered Holding By 40% During Last Year - Yahoo Finance
CVS Health (CVS) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
CVS Health (CVS) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
CVS Health Corporation (CVS): Is This High Growth Retail Stock Profitable in 2024? - Insider Monkey
Mirae Asset Global Investments Co. Ltd. Sells 8,763 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Is CVS Health Corporation (CVS) the Most Profitable Value Stock To Invest In? - Insider Monkey
CVS needs ‘realistic targets’ it can exceed says analyst after CEO dismissal - Yahoo Finance
CVS appoints new CEO amid restructuring - The Ticker
DekaBank Deutsche Girozentrale Has $113.86 Million Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS CEO Exit Ends Promising Era of Women Heading Pharmacy Chains - MSN
CVS Caremark To Report Q4 Results: Earnings Preview - RTTNews
CVS Caremark Q4 Profit Slightly Down; Adj. EPS Tops ViewUpdate - RTTNews
CVS Caremark Q3 Profit Rises; Lifts FY11 EPS ViewUpdate - RTTNews
CVS Caremark Operating Chief Merlo To Become CEO In March - RTTNews
CVS Caremark Q4 Results Tops Estimates, Lifts 2013 Outlook - RTTNews
CVS names Joyner as CEO under investor pressure, withdraws profit forecast - MSN
International Assets Investment Management LLC Buys 1,133,184 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Health insurers unveil Medicare Advantage plans for 2025 - MSN
More US firms lean on retired, veteran leaders to steady ship in choppy economy - MSN
Inside CVS and Walgreens' downturn: How misguided M&A damaged America's drugstores - Fortune
CVS Health Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
How misguided M&A damaged America’s drugstores - Yahoo Finance
CVS Health Co. (NYSE:CVS) Shares Purchased by Cullinan Associates Inc. - MarketBeat
Analysis-Can the new CVS CEO handle the Aetna challenge? - MSN
CVS shows women are hired to do impossible jobs - Victoria Advocate
CVS Health Corp. stock underperforms Thursday when compared to competitors - MarketWatch
SoCal Union Workers, CVS Reach Tentative Agreement - Progressive Grocer
CVS Q3 Estimates Plunge Before Earnings Release: How to Play the Stock - Yahoo Finance
CVS Health Stock Dip: Undervalued And Ready For A Turnaround (NYSE:CVS) - Seeking Alpha
A new CVS partnership supports coordinated health care, free Uber rides to appointments - The Atlanta Journal Constitution
Mizuho cuts CVS Health stock price target, keeps Outperform rating - Investing.com
Is CVS Health (NYSE:CVS) Using Too Much Debt? - Yahoo Finance
SOL Capital Management CO Acquires 9,075 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
CVS헬스 (CVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
CVS헬스 주식 (CVS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Mahoney Michael F | Director |
May 02 '24 |
Buy |
54.49 |
9,181 |
500,294 |
9,356 |
| Shah Prem S | EVP and Pres-Pharm, Consumer W |
Feb 16 '24 |
Sale |
76.95 |
29,473 |
2,267,947 |
39,765 |
| LUDWIG EDWARD J | Director |
Nov 03 '23 |
Buy |
70.47 |
2,000 |
140,930 |
20,630 |
0.53%
자본화:
|
볼륨(24시간):